Complying with the Occupational Safety and Health Administration's Bloodborne Pathogens Standard: implementing needleless systems and intravenous safety devices.
Preventing the transmission of bloodborne pathogens to healthcare workers has been a mission and a challenge of the healthcare industry for over 20 years. The development of the Occupational Safety and Health Administration Bloodborne Pathogens Standard in 1991 and the passing of the Needlestick Safety Act in 2000 mandated hospitals to develop an Exposure Control Plan to protect workers from these pathogens. Children's Hospital Boston began implementation of a needleless system in 1993. Employees readily accepted these systems into practice, because they were convenient and easy to use. A marked decrease in exposures to bloodborne pathogens naturally followed, which is consistent with the national data. The transition to intravenous (i.v.) safety devices at Children's Hospital began in 2000 and proved to be more of a challenge. First, the clinicians must choose a safety product, which requires developing and implementing a trial plan with potential catheters. This selection process is especially difficult in pediatrics where successful placement of the smallest-gauge catheter, no. 24, is imperative. After choosing an i.v. safety product, successful transition is dependent upon the thoroughness of i.v. safety device training and a commitment by the clinicians to the use of these products. Although the number of needlestick injuries and subsequent transmission of bloodborne pathogens have been further reduced with the use of i.v. safety devices, needlestick injuries still occur. This results from a lack of familiarity with the engineering of the device and therefore poor technique or a failure to activate the safety mechanism. Staff resistance due to loss of expertise with the new device and patient care concerns are additional barriers to the use of these new products. Addressing these obstacles and providing adequate training for all clinicians were required for successful implementation of these i.v. safety devices.
Marini
Michelle A
MA
*Emergency Services, Children's Hospital, Boston, MA; †Intravenous Therapy Team, Children's Hospital, Boston, MA; ‡Occupational Health Services, Children's Hospital, Boston, MA.
Giangregorio
Maeve
M
Kraskinski
Joanna C
JC
D001291:Attitude of Health Personnel; D017848:Blood-Borne Pathogens; D001900:Boston; D002404:Catheterization; D003264:Containment of Biohazards / Q000592:standards*; D003428:Cross Infection / Q000517:prevention & control; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D004867:Equipment Design; D015386:Hazardous Substances; D006776:Hospitals, Pediatric; D017053:Infection Control / Q000379:methods / Q000592:standards*; D007275:Injections, Intravenous / Q000295:instrumentation*; D007757:Laboratory Infection / Q000517:prevention & control; D017744:Medical Waste Disposal; D016602:Needlestick Injuries / Q000517:prevention & control*; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure; D010564:Personnel, Hospital / Q000523:psychology; D018962:Phlebotomy / Q000295:instrumentation; D012449:Safety; D014481:United States; D014489:United States Occupational Safety and Health Administration / Q000592:standards
D015386:Hazardous Substances; D017744:Medical Waste Disposal